NFL Alum i Health to suppo t HMO membe e gageme t Relatio ship ce te s o imp ovi g membe GLP-1 elated outcomes th ough use of the Health Lives He e app a d easy access to telehealth, pha macy a d lab testi g se vices Aim is to educe hospitalizatio s a d adve se d ug eve ts fo patie ts o GLP-1 the apy
The p og am outli ed i the MOU aims to imp ove medicatio adhe e ce, Healthca e Effective ess Data a d I fo matio Set (HEDIS) a d Ce te s fo Medica e & Medicaid Se vices (CMS) sta ati gs, i itially i obesity a d diabetes membe s. The HMO se ves Medica e Adva tage membe s i cludi g Ch o ic Special Needs Pla (C-SNP), a d Dual Eligible Special Needs Pla (D-SNP) be eficia ies.
The p oposed p og am would ge e ate eve ue fo DataMEDS o a ‘pe membe pe mo th’ (PMPM) model fo use of the HLH app fo all HMO membe s, with additio al eve ue ge e ated th ough a add-o GLP-1 ecepto ago ist d ug patie t ma ageme t p og am. Additio al oppo tu ities fo DataMEDS eve ue ge e atio elated to pha macy dispe si g, diag ostic lab testi g a d medical food p oducts may a ise as pa t of the oppo tu ity. DataMEDS’ etail pha macy Co exa Pha macy is i – etwo k with the HMO’s pha macy be efits ma age (PBM) a d Medica e. The Compa y’s diag ostic labo ato y, Helomics, is i – etwo k with Medica e. The compa ies expect to execute defi itive ag eeme ts i the fou th qua te of 2026 to begi olli g out the app to membe s i the fi st qua te of 2027. The MOU is o -bi di g a d is subject to defi itive ag eeme ts.
“HMOs ep ese t a sig ifica t oppo tu ity fo DataMEDS a d Health Lives He e,” said Ge ald Commissio g, I te im Co-CEO of DataMEDS. “While we have bee actively addi g tech ologies to ou platfo m to imp ove ou offe i g, we have bee mi dful to e su e that we a e ot o ly ma keti g Health Lives He e di ect-to-co sume (DTC), but also to o ga izatio s that ma age patie ts. This ag eeme t positio s us to add ou fi st co po ate custome that will allow us to fi e-tu e ou offe i g fo the eeds of payo s. This f amewo k ope s the doo to p ovidi g payo g oups with a platfo m they ca easily impleme t to help imp ove efficie cy a d facilitate membe e gageme t.”
DataMEDS AI, I c. (NASDAQ:MEDS), fo me ly Wellgistics Health, I c., is a healthca e compa y focused o the ve tical i teg atio of tech ology, pha macy, pha maceutical-adjace t a d telemedici e busi ess u its th ough its health i fo matio tech ology platfo ms to delive a bette expe ie ce fo co sume s a d p ovide s. Headqua te ed i Tampa, Fla., DataMEDS i co po ates its Ei stei Rx™ a tificial i tellige ce platfo m a d Pha macyChai ™ blockchai -e abled sma t co t acts platfo m i to the Health Lives He e mobile applicatio f om Tollo Health, LLC, a d its pha macy- elated Co exa Health subsidia y p ovides pha macy dispe si g a d pha macy- elated se vices, i cludi g dist ibutio of p oducts developed by Tollo Health. DataMEDS also ow s Helomics Co po atio , a Pittsbu gh, PA-based comme cial cli ical molecula diag ostics labo ato y focused o the ChemoFx® Assay chemothe apy selectio diag ostics test that aims to help o cologists make chemothe apy t eatme t decisio s. Lea mo e at https://datamedsai.com.
Tollo Health, LLC is a healthca e compa y comme cializi g p op ieta y medical foods a d dieta y suppleme ts a d, th ough TolloBio, developi g biopha maceutical ca didates, alo gside its Health Lives He e mobile applicatio . Co exa Health, a subsidia y of DataMeds AI, I c., dist ibutes select Tollo Health medical foods a d dieta y suppleme ts u de a wholesale dist ibutio a a geme t.
This p ess elease co tai s fo wa d-looki g stateme ts withi the mea i g of the P ivate Secu ities Litigatio Refo m Act of 1995. These stateme ts a e based o ma ageme t’s cu e t expectatio s a d a e ot p edictio s of actual pe fo ma ce. Fo wa d-looki g stateme ts i clude, without limitatio , stateme ts ega di g; the timi g of the Health Lives He e ollout to HMO membe s; PMPM p ici g, the add-o GLP-1 ecepto ago ist patie t ma ageme t p og am, a d membe uptake a d e gageme t; the p og am’s ability to imp ove medicatio adhe e ce, HEDIS measu es o CMS Sta Rati gs, o to educe hospitalizatio s o adve se d ug eve ts; NFL Alum i Health’s pa ticipatio i membe e gageme t activities, a d the complia ce of those activities with CMS Medica e ma keti g a d commu icatio s equi eme ts a d FTC e do seme t guida ce; additio al eve ue oppo tu ities f om pha macy dispe si g, diag ostic lab testi g a d medical food p oducts; elated-pa ty a a geme ts with Tollo Health, LLC; complia ce with fede al a d state f aud a d abuse laws, i cludi g the A ti-Kickback Statute a d be eficia y i duceme t ules, a d with HIPAA a d othe p ivacy a d secu ity laws; depe de ce o a si gle i itial paye custome a d the Compa y’s ability to secu e additio al co po ate custome s; competitio f om othe telehealth a d digital health compa ies; the Compa y’s ability to mai tai complia ce with Nasdaq listi g sta da ds; a d the Compa y’s liquidity, capital esou ces a d ability to fu d ope atio s. Actual esults may diffe mate ially f om those exp essed o implied i these fo wa d-looki g stateme ts due to a umbe of isks a d u ce tai ties, i cludi g those desc ibed u de “Risk Facto s” i the Compa y’s most ece t A ual Repo t o Fo m 10-K a d subseque t fili gs with the Secu ities a d Excha ge Commissio . Reade s a e cautio ed ot to place u due elia ce o these fo wa d-looki g stateme ts, which speak o ly as of the date of this p ess elease. The Compa y u de takes o obligatio to update o evise a y fo wa d-looki g stateme ts, except as equi ed by law.
James Lambe t, Vice P eside t, Rube stei Public Relatio s212.805.3024 | jlambe t@ ube stei p .com
View the o igi al p ess elease o ACCESS Newswi e
